Delivery Order SPE2DB22D3016-SPE2DB24FBGH7
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,811.06, is a Delivery Order for the supply of GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML, a specialty pharmaceutical product. This award is not designated as a set-aside.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,888.51 firm fixed-price contract is for the delivery of Granix 300 mcg syringes, a specialty medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, issued by the Defense Logistics Agency (DLA), is for the delivery of 4565153322 GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML pharmaceutical products. The firm-fixed-price delivery order, valued at $2,070.44, has a period of performance through July 16, 2024. This award is not associated with a set-aside program.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML pharmaceutical products. The $1,225.22 order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The order does not have a set-aside designation and...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FAPQ3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,817.31 firm fixed price delivery order is for the supply of 4563906351 "SYR DLV SYS GRANIX 480 MCG TBO" to support military treatment programs and facilities.
Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
This contract award to Amerisourcebergen Drug Corp. (Corporate Office Division) was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GRANIX 300 MCG/ML VIALML, a pharmaceutical product. The $2,462.88 firm-fixed-price contract has an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,547.50 firm-fixed-price delivery order is for the supply of Gel-One 30 mg/3 ml syringes, with an ultimate completion date of October 3, 2022. This contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,989.64 firm fixed-price delivery order is for the medical product "ADBRY 150 MG/ML SYRINGEML" and has an ultimate completion date of November 1, 2023.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products to the Defense Logistics Agency (DLA). The $7,298 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 27, 2024, with a completion date of December 19, 2024. The contract award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.35, is for the delivery of INFANRIX SYRINGE 10S, a medical product. The contract has a completion date of January 6, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...